UPB

19.62

0.86% -0.17

Handel nachbörslich: 19.62

Upstream Bio Inc (UPB)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$19.79

Offen:

$19.8

24-Stunden-Volumen:

271.77K

Relative Volume:

0.56

Marktkapitalisierung:

$1.06B

Einnahmen:

$2.22M

Nettoeinkommen (Verlust:

$-40.51M

KGV:

-15.27

EPS:

-1.2847

Netto-Cashflow:

$-46.53M

1W Leistung:

+5.31%

1M Leistung:

+10.22%

6M Leistung:

+206.56%

1J Leistung:

+0.00%

1-Tages-Spanne:

$19.46

$20.68

1-Wochen-Bereich:

$18.18

$20.68

52-Wochen-Spanne:

$5.14

$29.46

Upstream Bio Inc Stock (UPB) Company Profile

Firmenname

Upstream Bio Inc

Sektor

Healthcare (1141)

Branche

Biotechnology (637)

Telefon

781-208-2466

Adresse

890 WINTER STREET, SUITE 200, WALTHAM

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

UPB's Discussions on Twitter

Vergleichen Sie UPB mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
UPB Upstream Bio Inc	19.62	1.07B	2.22M	-40.51M	-46.53M	-1.2847
VRTX Vertex Pharmaceuticals Inc	407.79	106.37B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	460.46	59.90B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	564.63	60.40B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	796.92	49.56B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	320.10	36.88B	4.56B	-176.77M	225.30M	-1.7177

Upstream Bio Inc Stock (UPB) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-11-05	Eingeleitet	JP Morgan	Overweight
2024-11-05	Eingeleitet	Piper Sandler	Overweight
2024-11-05	Eingeleitet	TD Cowen	Buy
2024-11-05	Eingeleitet	William Blair	Outperform

Upstream Bio Inc Aktie (UPB) Neueste Nachrichten

Oct 09, 2025

Upstream Bio's (UPB) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 09, 2025

Will Rising Interest Rates Hurt Vintage Coffee and Beverages Limiteds Profit MarginsMonthly Performance Summary & Free Stop-Loss Planning for Your Portfolio - earlytimes.in

Oct 09, 2025

Measuring Upstream Bio Inc.’s beta against major indicesJuly 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - newser.com

Oct 09, 2025

What does recent volatility data suggest for Upstream Bio Inc.Weekly Profit Analysis & Stepwise Entry and Exit Trade Signals - newser.com

Oct 09, 2025

Oct 07, 2025

What drives Upstream Bio Inc stock priceVolume Weighted Average Price & Plan Your Future With Strategic Investing - earlytimes.in

Oct 07, 2025

Oct 06, 2025

Visualizing Upstream Bio Inc. stock with heatmapsJuly 2025 Rallies & Technical Analysis for Trade Confirmation - newser.com

Oct 06, 2025

Oct 05, 2025

Can volume confirm reversal in Upstream Bio Inc.Trade Entry Report & AI Forecasted Entry/Exit Points - newser.com

Oct 05, 2025

Applying Elliott Wave Theory to Upstream Bio Inc.July 2025 Setups & Daily Stock Trend Watchlist - newser.com

Oct 05, 2025

Oct 04, 2025

Upstream Bio (UPB): Assessing Valuation as Shares Climb 7% Over the Past Week - Yahoo

Oct 04, 2025

Oct 03, 2025

Assessing Upstream Bio (UPB) Valuation After New Verekitug Phase 2 Data and Investor Interest Surge - Sahm

Oct 03, 2025

Upstream Bio, Inc. (NASDAQ:UPB) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat

Oct 03, 2025

Why Upstream Bio (UPB) Is Up 14.0% After Positive Phase 2 Verekitug Data and Novel Dosing Approach - Sahm

Oct 03, 2025

News impact scoring models applied to Upstream Bio Inc.2025 Top Decliners & Safe Capital Growth Trade Ideas - newser.com

Oct 03, 2025

Is Upstream Bio Inc. forming a reversal patternJuly 2025 Update & Community Supported Trade Ideas - newser.com

Oct 03, 2025

Is Upstream Bio Inc. stock attractive for passive investorsMarket Growth Summary & AI Driven Stock Price Forecasts - newser.com

Oct 03, 2025

Earnings visualization tools for Upstream Bio Inc.July 2025 Earnings & Trade Opportunity Analysis - newser.com

Oct 03, 2025

Why retail investors pile into Upstream Bio Inc. stock2025 Market Outlook & Intraday High Probability Setup Alerts - newser.com

Oct 03, 2025

Oct 02, 2025

Upstream Bio Inc Stock Analysis and ForecastPrice Channel Trading & Free Popular Stock Picks Selection - earlytimes.in

Oct 02, 2025

Oct 01, 2025

Is Upstream Bio Inc. building a consolidation baseTrade Analysis Summary & Scalable Portfolio Growth Ideas - newser.com

Oct 01, 2025

Sep 30, 2025

Upstream Bio (NASDAQ:UPB) Trading 4.2% HigherStill a Buy? - MarketBeat

Sep 30, 2025

Upstream Bio Presents Data Showing Structural and Mechanistic Drivers of Verekitug’s Potent Pharmacodynamic Activity and Differentiated Clinical Profile at European Respiratory Society Congress - The Manila Times

Sep 30, 2025

Upstream Bio Presents Data Showing Structural and - GlobeNewswire

Sep 30, 2025

24-Week TSLP Inhibition: Upstream Bio's Verekitug Shows Breakthrough Respiratory Disease Treatment Data - Stock Titan

Sep 30, 2025

Sep 29, 2025